(2S)-5-[[amino-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonylamino]methylidene]amino]-2-[[(2R)-4-[(2-methylpropan-2-yl)oxyamino]-2-(naphthalen-2-ylmethyl)-4-oxobutanoyl]amino]pentanoic acid
Product Name |
(2S)-5-[[amino-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonylamino]methylidene]amino]-2-[[(2R)-4-[(2-methylpropan-2-yl)oxyamino]-2-(naphthalen-2-ylmethyl)-4-oxobutanoyl]amino]pentanoic acid
|
Product Code |
DA-G042-i
|
Chemical name |
(2S)-5-[[amino-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonylamino]methylidene]amino]-2-[[(2R)-4-[(2-methylpropan-2-yl)oxyamino]-2-(naphthalen-2-ylmethyl)-4-oxobutanoyl]amino]pentanoic acid
|
Synonyms |
(S)-5-(((E)-amino((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran)-5-sulfonamido)methylene)amino)-2-((R)-4-(tert-butoxyamino)-2-(naphthalen-2-ylmethyl)-4-oxobutanamido)pentanoic acid;
|
Impurity |
NA
|
CAS Number |
1093740-20-5
|
Alternate CAS # |
NA
|
Molecular form |
C38H51N5O8S
|
Appearance |
NA
|
Melting Point |
NA
|
Mol. Weight |
737.91
|
Storage |
2-8°C Refrigerator
|
Solubility |
NA
|
Stability |
NA
|
Category |
impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals
|
Boiling Point |
NA
|
Applications |
Intermediate in the synthesis of substrate-selective peptide hydroxamate inhibitor of insulin-degrading enzyme.
|
Dangerous Goods Info |
NA
|
References |
NA
|
Extra Notes |
NA
|
Documents (MSDS) |
No Data Available
|
Keywords |
NA |